Novavax, Inc. (Nasdaq: NVAX) announced that the enrollment of over 3,500 subjects in Mexico has been completed in Stage B of its pivotal 2009 H1N1 virus-like-particle (VLP) pandemic influenza vaccine study. With the 1,000 subjects already enrolled in Stage A of the trial, the enrollment in this pivotal trial is now complete with over 4,500 subjects...
Read more...

If the behavior of the seasonal form of the H1N1 influenza virus is any indication, scientists say that chances are good that most strains of the pandemic H1N1 flu virus will become resistant to Tamiflu, the main drug stockpiled for use against it...
Read more...

Normally, this is the peak period for the flu in the United States. But that just doesn't seem to be the case this year. The number of states reporting widespread cases of the flu mysteriously plunged from 49 at the end of October to zero at the beginning of the January, according to the Centers for Disease Control and Prevention...
Read more...

Rwanda Targets Communities In Effort To Curb Maternal Mortality To reduce maternal mortality in Rwanda and reach U.N. Millennium Development Goal targets, the government will conduct maternal death audits in villages to help identify ways to improve outcomes, Rwanda's Minister of Health Richard Sezibera announced recently, the New Times/allAfrica.com reports...
Read more...